There was a light wind blowing as the cardiologist, Harold 'Jeremy' Swan sat on the beach at Santa Monica, California in 1969 1 . A passing yacht flying a spinnaker led him to wonder whether a sail or parachute attached to the end of a flexible catheter would solve a problem he had been contemplating for several years.
Born in Ireland, Jeremy Swan studied medicine at St Thomas' Hospital in London and by 1969 was Chief of the Division of Cardiology at Cedars-Sinai Medical Center in Los Angeles, California. He had previously spent 14 years at the Mayo Clinic and had been director of the Mayo Laboratory at St Mary's Hospital in Rochester, with over 100 peer-reviewed publications to his name 2 . A pioneer of cardiac catheterisation and a leader in the field of congenital heart disease, he found once he moved to Cedars-Sinai that the majority of his patients were suffering from ischaemic heart disease. He noted "it was apparent to me that a safe approach to RHC [right heart catheterisation] was essential if this disorder was to be better understood" 1 . Conventional techniques required stiff or semi-stiff catheters and their manipulation through the right heart caused ectopy. A student of his, Ronald Bradley, had been experimenting with finegauge silastic tubing in an attempt to reach the pulmonary artery but with very limited success. After admiring the spinnaker on the beach, Swan approached Edwards Laboratories with his idea. At their suggestion, a balloon was substituted for a spinnaker and a catheter was fabricated for animal experiments.
Swan's colleague, William Ganz, had left Czechoslovakia for Los Angeles in 1966 to escape the political situation. He joined the cardiology team at Cedars-Sinai and was appointed Professor of Medicine with a special interest in thermodilution blood flow measurement. Ganz carried out the original animal experiments with the balloon-directed catheter and, after the success of these tests, the device was used on humans with and without fluoroscopy. "Federal device legislation and institutional review boards did not exist at the time so, with other colleagues, we proceeded directly to bedside catheterization in the coronary care unit."
They had no serious complications. Initially their aim was to perform right heart catheter studies in less than 30 minutes in patients with acute myocardial infarction to determine presenting haemodynamics. As the study expanded they began to study the effects of treatment protocols and left the catheters in situ for one to two days. The pulmonary artery catheter therefore evolved from a diagnostic tool into a monitoring device during these early studies. As the use of the catheters grew, physicians other than cardiologists began inserting the catheters and these were left in for longer periods. Inevitably, complications eventually developed; they were rare but included arterial and cardiac rupture, endocarditis, sepsis and thrombosis.
There were three stated objectives in the first clinical studyplacement of a catheter in the pulmonary artery without associated ventricular arrhythmias, prompt and reliable passage to the pulmonary artery and passage without fluoroscopy 3 . Arrhythmias were less frequent with these catheters and the other objectives were all met. They reported 10 cases of balloon failure in the ward, which is not surprising given that "In all cases of balloon failure, the catheter had been allowed to remain in place for several days and had previously been used one or more times". They resolved to make the catheter single use once adequate supplies were available. The following year Ganz's work on thermodilution resulted in the addition of a thermistor to the end of the catheter to allow measurement of cardiac output 4 .
Swan-Ganz or pulmonary artery (PA) catheters rapidly became an important tool for the evaluation and treatment of critically ill patients. By 1993 an estimated two million catheters were sold annually in the United States and many groups had issued statements about the appropriate indications for PA catheters 5 . Anaesthetists had been very quick to adopt this new technology and there are many references to the use of PA catheters in the anaesthetic literature from 1972 onwards. In 1991 the American Society of Anesthesiologists established a task force "to examine the evidence for benefits and risks from PA catheterization and its rationale, based on scientific evidence and expert opinion... A total of 860 clinical trials, controlled observational studies, uncontrolled case reports, and individual case reports were considered". The recommendations ran to many pages but essentially supported the use of PA catheters in surgical settings associated with increased risk due to haemodynamic changes. It was noted that additional research was required.
The guidelines were revisited in 2003 after a number of studies, in particular one by Connors and colleagues, raised doubts about the effectiveness and safety of the catheters 6 . Ultimately, little changed as the task force concluded "Most trials have focused on patients in ICUs and have yielded data of only tangential relevance to conditions in the operating room" 7 .
Shortly after that publication Sandham and colleagues reported a randomised controlled trial of PA catheters in high-risk surgical patients. They concluded "We found no benefit to therapy directed by pulmonary-artery catheters over standard care in elderly, high-risk patients requiring intensive care" 8 . This trial studied a particular group of patients and the results cannot be extrapolated, but it demonstrated that it is possible to design and execute trials of technology in common usage. In an editorial Parsons wrote of Sandham's research, "These debates represent the progress we have made in research related to critical care and the difficulty posed by the legacy of an over-enthusiastic embracing of technology without adequate assessment. I hope that we are learning from our experience" 9 .
There is no doubt that the Swan-Ganz catheter was a great advance in diagnostic cardiac catheterisation; whether it is a useful anaesthetic monitor is currently open to debate.
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